Abstract: A medicine for the treatment of Meniere's disease containing, as an active ingredient, erythritol which is capable of significantly reducing the endolymphatic pressure by oral administration of a therapeutically effective amount of erythritol as an active substance.
Type:
Grant
Filed:
April 14, 2000
Date of Patent:
June 12, 2001
Assignee:
Nikken Chemicals, Co., LTD
Inventors:
Jun Kojima, Shingo Yanagida, Takeshi Otani